Humana stock bounces after Medicare Advantage rate shock; what traders are watching next
Humana shares rose 1.5% to $196.94 Thursday afternoon after steep losses earlier in the week, triggered by a U.S. proposal for a 0.09% Medicare Advantage payment hike in 2027. The stock had plunged 21% Tuesday and another 6.7% Wednesday. Investors await Humana’s quarterly results Feb. 11 and the final Medicare rate decision in April.